Professor Klaus Brehm from Würzburg is granted 750,000 euros for a new research project on tapeworms. His work may bring advances in fighting worm infections, but also in wholly different areas of medicine.
Parasitic worms are a major problem worldwide, especially in developing countries. In tropical regions, for example, several million people are suffering from schistosomiasis. In the course of this infectious disease, worms damage the liver and other organs. They can even cause cancer.
Millions of people are infected with tapeworms. Particularly dangerous: dog and fox tapeworms. Their larvae form cysts in the tissue of the lung, liver or brain. These cysts proliferate or grow in the body much like tumours to reach a considerable size in some cases. In some species this can cause complications such as blindness and epilepsy, with others it may lead to death.
There have been no vaccines against these pathogens so far and only a very limited repertoire of drugs. Tapeworm cysts, for example, can only be kept in check with a lifelong chemotherapy. Once treatment is stopped, they will simply continue to grow. In Germany, around 50 people are infected with the fox tapeworm each year. This seems little compared to the figures worldwide, however, this is hardly a comfort to those affected.
Wellcome Trust funds research consortium
An international research consortium now wants to find new strategies to combat schistosomiasis and tapeworms. The Wellcome Trust, the UK's largest private funder of biomedical and veterinary research, supports the project: It promotes the "Flatworm Functional Genomics Initiative" with a Strategic Award worth five million euros. The project is set to start in late 2015 to run for five years.
Around 750,000 euros of the grant will be allocated to the team of Professor Klaus Brehm, a tapeworm expert, at the Institute of Hygiene and Microbiology of the University of Würzburg. The money is highly welcome, because: "We are far behind in our knowledge of worm parasites in infection research," as Brehm puts it. He attributes this to the fact that the tapeworm genome was only recently mapped. Moreover, there are no methods available to analyse the worms' genetic functions in the lab. But this would be necessary to find potential targets for drugs or vaccines.
Investigating the worms' genetic functions
After all: The DNA of four tapeworm species was mapped in 2013. Brehm was involved in this work which was equally funded by the Wellcome Trust and was published in the journal "Nature". "Now we have to develop methods to manipulate the worms' genes, because you have to be able to knock out a gene to understand its function."
Brehm designates the venture as a "high-risk project", meaning that it is so ambitious that the scientists could come out without a result after the project term. "But if we are successful, we will considerably advance the research in this field," the Würzburg professor adds.
Perfectly camouflaged to hide from the immune system
The scientists are not only interested in new drugs and vaccines. They see another potential benefit in the tapeworm cysts: These dangerous structures are attached to the human body like perfectly transplanted organs; they cannot be harmed by the immune system.
"How do the worms manage to camouflage themselves so efficiently? Finding the answer to that question could mean progress for organ transplantation," Brehm says. It is conceivable, for example, to disguise transplanted organs accordingly to protect them against the immune system's attack. The treatment of allergies and autoimmune diseases, too, could benefit from a better understanding of the strategies used by the worms to keep the immune system at bay.
The names of the project partners
The FUGI project (Flatworm Functional Genomics Initiative) is led by Professor Karl Hoffmann of the Aberysthwyth University in the UK.
Other partners are Matthew Berriman (Wellcome Trust Sanger Institute, UK), Ludovic Vallier (Cambridge University, UK), Professor Christoph Grunau (University of Perpignan and Centre National de la Recherche Scientifique, France), Professor Klaus Brehm (University of Würzburg, Germany), James Collins (University of Texas Southwestern Medical Center, USA), and Professor Paul Brindley (George Washington University, USA).
Nature publication on the tapeworm genome
“The genomes of four tapeworm species reveal adaptations to parasitism”, Nature 496, 57-63, 4. April 2013, DOI: 10.1038/nature12031
Prof. Dr. Klaus Brehm, Institut für Hygiene und Mikrobiologie, Universität Würzburg, phone +49 931 31-46168, firstname.lastname@example.org
Robert Emmerich | idw - Informationsdienst Wissenschaft
A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences